NCT00939393

Brief Summary

Endoscopic sinus surgery will be performed either in the physician's office or in the operating room (OR). Patients treated in the physician's office will have endoscopic sinus surgery performed with balloon sinuplasty devices. Patients treated in the OR will have endoscopic sinus surgery performed with or without balloon sinuplasty devices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 14, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 15, 2009

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
4.3 years until next milestone

Results Posted

Study results publicly available

October 3, 2014

Completed
Last Updated

July 12, 2024

Status Verified

July 1, 2024

Enrollment Period

1.2 years

First QC Date

July 14, 2009

Results QC Date

May 6, 2014

Last Update Submit

July 10, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean Intra-patient Change in SNOT-20 Score at 24 Weeks Post-procedure Compared to Baseline

    The 20 question Sino-Nasal Outcome Test (SNOT-20) will be used to evaluate sinus symptoms and sinus-symptom related quality of life (QOL) at baseline, 1 week, 4 weeks, 24 weeks and 52 weeks post-procedure. The change in SNOT-20 score at each post-procedure time point will be evaluated compared to baseline SNOT-20 score. Each of the 20 questions in the SNOT-20 survey is scored on a scale of 0 to 5, where '0' represents 'no problem' and '5' represents 'problem as bad as it can be'. The 20 questions are expressed as a mean of the scores. Therefore, the minimum mean score is zero and the maximum mean score is 5.

    24 weeks

Secondary Outcomes (9)

  • Mean Intra-patient Change in Lund-MacKay CT Score [24 Weeks]

    24 weeks

  • Proportion of Participants Rating Procedure as Tolerable (IO Only)

    Day 0

  • Proportion of Participants Reporting No Pain or Pain of Low Intensity (IO Only)

    Day 0

  • Mean Number of Debridements Per Participant (IO Only)

    52 weeks

  • Proportion of Participants With Revisions (IO Only)

    52 weeks

  • +4 more secondary outcomes

Study Arms (2)

FESS in OR with or without balloons

ACTIVE COMPARATOR

Functional Endoscopy Sinus Surgery

Device: FESS instruments with or without balloon treatment

Balloon sinuplasty in physician office

ACTIVE COMPARATOR

Balloon Sinuplasty in physician office using Acclarent devices

Device: Balloon Sinuplasty

Interventions

Balloon dilatation of sinuses

Balloon sinuplasty in physician office

Intervention with metal instruments with or without balloon treatment

FESS in OR with or without balloons

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years and greater
  • Both male and female patients eligible
  • Diagnosis of chronic sinusitis that is not responsive to medical management (\> 12 weeks of symptoms and failed at least 3 to 6 weeks of appropriate antibiotic therapy as evidenced by presence of disease on CT scan)
  • Planned endoscopic sinus surgery (recommended by investigator, consented to by patient)

You may not qualify if:

  • Cystic fibrosis
  • Samter's Triad (Aspirin sensitivity, Asthma, Sinonasal polyposis)
  • Sinonasal tumors or obstructive lesions
  • History of facial trauma that distorts sinus anatomy and precludes access to the sinus ostium
  • Ciliary dysfunction
  • Pregnant females

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rockside Road Surgery Center

Independence, Ohio, 44131, United States

Location

Results Point of Contact

Title
Clinical Director
Organization
Acclarent, Inc.

Study Officials

  • Howard Levine, MD

    Rockside Road Surgery Center Independence, OH

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
GT60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2009

First Posted

July 15, 2009

Study Start

April 1, 2008

Primary Completion

June 1, 2009

Study Completion

July 1, 2010

Last Updated

July 12, 2024

Results First Posted

October 3, 2014

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations